A composite 18F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026)
2025 · The Breast · 2 citations
https://doi.org/10.1016/j.breast.2025.104432
V
V. Valero
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
72
Papers
1.1K
Citations
13
h-index
16
i10-index
V. Valero is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Treatment and Pharmacology & Advanced Breast Cancer Therapies. The author has an h-index of 13, co-authored 62 publications.
Papers by this author
works202P Early brain relapse in stage III inflammatory breast cancer occurs independent of molecular subtype
2025 · ESMO Open · 0 citations
https://doi.org/10.1016/j.esmoop.2025.104756
Neoadjuvant HER2-targeted regimens with or without anthracyclines for HER2-positive inflammatory breast cancer: a multicenter retrospective study
2025 · Breast Cancer Research and Treatment · 0 citations
https://doi.org/10.1007/s10549-025-07795-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat